Developments include cell-based and recombinant DNA technologies. The global influenza vaccine market is projected to cross $14b by 2032, according to DelveInsight. The sector’s expansion is ...

The move comes after Commission Chairman Clint Didier invited a group of vaccine skeptics to speak at two recent meetings. It’s the same group behind recent pushes in Idaho to stop offering the ...